When you publish results from your use of GM/CA beamlines, you are required to acknowledge the GM/CA funding sources in your publications. This requirement applies to all NIH and DOE support and is used by funding agencies to evaluate our program. Please copy and paste the following statement into your publications:
"GM/CA@APS has been funded by the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006, P30GM138396). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357".
If you used 23-ID-B after April 2016, please include: "The Eiger 16M detector was funded by NIH grant S10OD012289".
If you used 23-ID-D before May 2023, you
do not separately need to acknowledge use of the Pilatus 3 6M detector.
If you used 23-ID-D after September 2025,
please include: "The Eiger2 XE 16M detector was funded by NIH grant
S10OD034267".
GM/CA @ APS
